These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization. Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release. Cervia D; Fiorini S; Pavan B; Biondi C; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):200-9. PubMed ID: 11882916 [TBL] [Abstract][Full Text] [Related]
4. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation. Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435 [TBL] [Abstract][Full Text] [Related]
5. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins. Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012 [TBL] [Abstract][Full Text] [Related]
6. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells. Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284 [TBL] [Abstract][Full Text] [Related]
7. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Liu Q; Cescato R; Dewi DA; Rivier J; Reubi JC; Schonbrunn A Mol Pharmacol; 2005 Jul; 68(1):90-101. PubMed ID: 15855408 [TBL] [Abstract][Full Text] [Related]
8. Drug design at peptide receptors: somatostatin receptor ligands. Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway. Grilli M; Raiteri L; Pittaluga A Neuropharmacology; 2004 Mar; 46(3):388-96. PubMed ID: 14975694 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773 [TBL] [Abstract][Full Text] [Related]
15. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620 [TBL] [Abstract][Full Text] [Related]
16. Differential desensitization of somatostatin receptor subtypes in atT-20 cells. Mazza FC; Blake AD Protein Pept Lett; 2004 Apr; 11(2):141-7. PubMed ID: 15078202 [TBL] [Abstract][Full Text] [Related]
17. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation. Spary EJ; Maqbool A; Batten TF J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081 [TBL] [Abstract][Full Text] [Related]
18. Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs. Cervia D; Fehlmann D; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):578-87. PubMed ID: 12750875 [TBL] [Abstract][Full Text] [Related]
19. [New medical treatments in pituitary adenomas]. Drutel A; Caron P; Archambeaud F Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854 [TBL] [Abstract][Full Text] [Related]
20. Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors. Schmid HA; Schoeffter P Neuroendocrinology; 2004; 80 Suppl 1():47-50. PubMed ID: 15477717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]